Makers of e-Cigs, Liquid Vapes Potentially Targeting Children Pull Products
Makers of e-Cigs, Liquid Vapes Potentially Targeting Children Pull Products
Sara is a credited freelance writer, editor, contributor, and essayist, as well as a novelist and poet with nearly twenty years of experience. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She has an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling, graduating with a 4.2/4.0 GPA. She is also a member of Chi Sigma Iota and a 2020 recipient of the Donald D. Davis scholarship recognizing social responsibility. Sara is certified in children's book writing, HTML coding and social media marketing. Her fifth book, PTSD: Healing from the Inside Out, was released in September 2019 and is available on Amazon. You can find her others books there, too, including Narcissistic Abuse: A Survival Guide, released in December 2017.
Makers of e-Cigs, Liquid Vapes Potentially Targeting Children Pull Products
PAX Labs introduced its electronic cigarette, called JUUL, in June 2015, and although the marketing campaign wasn’t specifically geared toward teens, a former senior manager said that he and others in the company were well aware it could appeal to them. After the device hit the streets, teenagers immediately began posting images of themselves “JUULing”
New York City Garbage Hauler Required to Halt Operations
Thousands of Embryos Destroyed in Fertility Clinic Malfunction, Lawsuits Filed
Nursing Home Disregards Its Residents’ Lifesaving Medical Wishes
For Three Years Inmate with Lymphoma was Treated for Psoriasis
New Drugs Added to FDA’s Recall List, Some Include Valsartan
General Mills’ Cereal Bars Are Not 100 Percent Natural
Facebook Removes Advertising Attributes, Claims Unrelated to Discrimination Accusations
Pfizer’s CEO is Offered Compensation Increase as Drug Prices Soar